Total Payments
$85,128
2024 Payments
$8,242
Companies
34
Transactions
525
Medicare Patients
531
Medicare Billing
$68,003
Payment Breakdown by Category
Other$67,775 (79.6%)
Food & Beverage$16,608 (19.5%)
Travel$691.89 (0.8%)
Education$53.66 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,775 | 30 | 79.6% |
| Food and Beverage | $16,608 | 486 | 19.5% |
| Travel and Lodging | $691.89 | 6 | 0.8% |
| Education | $53.66 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $70,108 | 173 | $0 (2024) |
| GENZYME CORPORATION | $2,028 | 63 | $0 (2024) |
| ALK-Abello, Inc | $1,811 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,790 | 41 | $0 (2024) |
| Genentech USA, Inc. | $1,251 | 26 | $0 (2024) |
| Optinose US, Inc. | $977.49 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $948.10 | 22 | $0 (2024) |
| CSL Behring | $755.22 | 30 | $0 (2024) |
| PFIZER INC. | $647.37 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $629.30 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,242 | 69 | GlaxoSmithKline, LLC. ($5,754) |
| 2023 | $14,229 | 99 | GlaxoSmithKline, LLC. ($12,172) |
| 2022 | $13,172 | 79 | GlaxoSmithKline, LLC. ($11,229) |
| 2021 | $11,466 | 52 | GlaxoSmithKline, LLC. ($10,576) |
| 2020 | $6,819 | 47 | GlaxoSmithKline, LLC. ($6,163) |
| 2019 | $22,375 | 73 | GlaxoSmithKline, LLC. ($20,394) |
| 2018 | $6,716 | 51 | GlaxoSmithKline, LLC. ($3,461) |
| 2017 | $2,108 | 55 | Genentech USA, Inc. ($499.78) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Immunology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $24.17 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $146.19 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Immunology | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $149.41 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 155 | 1,902 | $43,652 | $17,710 |
| 2022 | 4 | 127 | 2,006 | $41,661 | $17,509 |
| 2021 | 4 | 122 | 1,842 | $39,313 | $17,670 |
| 2020 | 5 | 127 | 1,814 | $35,995 | $15,114 |
Total Patients
531
Total Services
7,564
Medicare Billing
$68,003
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 126 | $16,632 | $8,503 | 51.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 24 | 1,699 | $16,990 | $5,232 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $7,200 | $3,097 | 43.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 17 | $1,530 | $467.25 | 30.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 20 | $1,300 | $411.24 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 123 | $16,236 | $8,327 | 51.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 24 | 1,830 | $18,300 | $6,106 | 33.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $5,760 | $2,633 | 45.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 15 | 21 | $1,365 | $442.26 | 32.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 122 | $15,488 | $8,764 | 56.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 23 | 1,662 | $16,620 | $5,526 | 33.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $5,580 | $2,765 | 49.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 15 | 25 | $1,625 | $614.16 | 37.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 122 | $13,420 | $6,769 | 50.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 22 | 1,627 | $16,270 | $5,444 | 33.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 32 | 32 | $4,800 | $2,204 | 45.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 14 | 17 | $1,105 | $464.82 | 42.1% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 11 | 16 | $400.00 | $232.58 | 58.1% |
About Dr. Pardeep Rihal, M.D
Dr. Pardeep Rihal, M.D is a Allergy & Immunology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982671632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pardeep Rihal, M.D has received a total of $85,128 in payments from pharmaceutical and medical device companies, with $8,242 received in 2024. These payments were reported across 525 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,775).
As a Medicare-enrolled provider, Rihal has provided services to 531 Medicare beneficiaries, totaling 7,564 services with total Medicare billing of $68,003. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Katy, TX
- Active Since 03/01/2006
- Last Updated 06/03/2010
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982671632
Products in Payments
- NUCALA (Biological) $69,717
- DUPIXENT (Biological) $2,267
- Odactra (Drug) $1,811
- Xolair (Biological) $1,401
- Xhance (Drug) $977.49
- Haegarda (Biological) $521.27
- TEZSPIRE (Biological) $445.57
- EUCRISA (Drug) $416.97
- FASENRA (Drug) $368.55
- DUPIXENT DUPILUMAB INJECTION (Biological) $348.46
- XOLAIR (Biological) $328.92
- OPZELURA (Drug) $320.92
- CINRYZE (Drug) $300.67
- CUVITRU (Biological) $299.38
- RINVOQ (Biological) $271.05
- Xembify (Biological) $270.18
- AYVAKIT (Drug) $268.07
- AIRSUPRA (Drug) $236.11
- Hizentra (Biological) $213.07
- DUPIXENT (Drug) $210.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.